195 related articles for article (PubMed ID: 12736721)
1. Genetic changes and expression of the mannose 6-phosphate/insulin-like growth factor II receptor gene in human hepatitis B virus-associated hepatocellular carcinoma.
Yang EB; Qin LL; Zhao YN; Zhang K; Chow P
Int J Mol Med; 2003 Jun; 11(6):773-8. PubMed ID: 12736721
[TBL] [Abstract][Full Text] [Related]
2. M6P/IGF2R tumor suppressor gene mutated in hepatocellular carcinomas in Japan.
Oka Y; Waterland RA; Killian JK; Nolan CM; Jang HS; Tohara K; Sakaguchi S; Yao T; Iwashita A; Yata Y; Takahara T; Sato S; Suzuki K; Masuda T; Jirtle RL
Hepatology; 2002 May; 35(5):1153-63. PubMed ID: 11981765
[TBL] [Abstract][Full Text] [Related]
3. Frequent loss of heterozygosity on 6q at the mannose 6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumors.
De Souza AT; Hankins GR; Washington MK; Fine RL; Orton TC; Jirtle RL
Oncogene; 1995 May; 10(9):1725-9. PubMed ID: 7753549
[TBL] [Abstract][Full Text] [Related]
4. Failure to detect genetic alteration of the mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) gene in hepatocellular carcinomas in Japan.
Wada I; Kanada H; Nomura K; Kato Y; Machinami R; Kitagawa T
Hepatology; 1999 Jun; 29(6):1718-21. PubMed ID: 10347113
[TBL] [Abstract][Full Text] [Related]
5. M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity.
De Souza AT; Hankins GR; Washington MK; Orton TC; Jirtle RL
Nat Genet; 1995 Dec; 11(4):447-9. PubMed ID: 7493029
[TBL] [Abstract][Full Text] [Related]
6. M6P/IGF2R is mutated in squamous cell carcinoma of the lung.
Kong FM; Anscher MS; Washington MK; Killian JK; Jirtle RL
Oncogene; 2000 Mar; 19(12):1572-8. PubMed ID: 10734317
[TBL] [Abstract][Full Text] [Related]
7. Imprinted M6p/Igf2 receptor is mutated in rat liver tumors.
Mills JJ; Falls JG; De Souza AT; Jirtle RL
Oncogene; 1998 May; 16(21):2797-802. PubMed ID: 9652747
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity of M6P/IGF2R gene is an early event in the development of prostate cancer.
Hu CK; McCall S; Madden J; Huang H; Clough R; Jirtle RL; Anscher MS
Prostate Cancer Prostatic Dis; 2006; 9(1):62-7. PubMed ID: 16304558
[TBL] [Abstract][Full Text] [Related]
9. Deletion of chromosomes 9p and 17 associated with abnormal expression of p53, p16/MTS1 and p15/MTS2 gene protein in hepatocellular carcinomas.
Shao J; Li Y; Li H; Wu Q; Hou J; Liew C
Chin Med J (Engl); 2000 Sep; 113(9):817-22. PubMed ID: 11776078
[TBL] [Abstract][Full Text] [Related]
10. [Significance and expression of insulin-like growth factor II and its receptor in hepatocellular carcinogenesis].
Fan Z; Yang D; Qin H
Zhonghua Gan Zang Bing Za Zhi; 2000 Apr; 8(2):84-6. PubMed ID: 10861110
[TBL] [Abstract][Full Text] [Related]
11. Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas.
Kim MY; Park E; Park JH; Park DH; Moon WS; Cho BH; Shin HS; Kim DG
Oncogene; 2001 Jul; 20(33):4568-75. PubMed ID: 11494152
[TBL] [Abstract][Full Text] [Related]
12. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
Tamori A; Nishiguchi S; Kubo S; Narimatsu T; Habu D; Takeda T; Hirohashi K; Shiomi S
J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260
[TBL] [Abstract][Full Text] [Related]
13. M6P/IGF2 receptor: a candidate breast tumor suppressor gene.
Hankins GR; De Souza AT; Bentley RC; Patel MR; Marks JR; Iglehart JD; Jirtle RL
Oncogene; 1996 May; 12(9):2003-9. PubMed ID: 8649861
[TBL] [Abstract][Full Text] [Related]
14. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Nardone G; Romano M; CalabrĂ² A; Pedone PV; de Sio I; Persico M; Budillon G; Bruni CB; Riccio A; Zarrilli R
Hepatology; 1996 Jun; 23(6):1304-12. PubMed ID: 8675143
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of the mannose 6-phosphate/ insulin-like growth factor-II receptor in human breast cancer cell lines of different invasive potential.
Xie S; Kang JX
Med Sci Monit; 2002 Aug; 8(8):BR293-300. PubMed ID: 12165733
[TBL] [Abstract][Full Text] [Related]
16. Altered ligand binding by insulin-like growth factor II/mannose 6-phosphate receptors bearing missense mutations in human cancers.
Devi GR; De Souza AT; Byrd JC; Jirtle RL; MacDonald RG
Cancer Res; 1999 Sep; 59(17):4314-9. PubMed ID: 10485478
[TBL] [Abstract][Full Text] [Related]
17. Deletion of the M6P/IGF2r gene in primary hepatocellular carcinoma.
Piao Z; Choi Y; Park C; Lee WJ; Park JH; Kim H
Cancer Lett; 1997 Nov; 120(1):39-43. PubMed ID: 9570384
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between mutation on precore region of integrated HBV DNA and p53 gene mutation in hepatocellular carcinoma].
Wang XH; Wang PL
Ai Zheng; 2003 Jul; 22(7):715-8. PubMed ID: 12866962
[TBL] [Abstract][Full Text] [Related]
19. Regulation of insulin-like growth factor II gene expression by hepatitis B virus in hepatocellular carcinoma.
d'Arville CN; Nouri-Aria KT; Johnson P; Williams R
Hepatology; 1991 Feb; 13(2):310-5. PubMed ID: 1847351
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive allelotype study of hepatocellular carcinoma: potential differences in pathways to hepatocellular carcinoma between hepatitis B virus-positive and -negative tumors.
Okabe H; Ikai I; Matsuo K; Satoh S; Momoi H; Kamikawa T; Katsura N; Nishitai R; Takeyama O; Fukumoto M; Yamaoka Y
Hepatology; 2000 May; 31(5):1073-9. PubMed ID: 10796882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]